Posters Late Abstracts

Basic and translational research in psoriasis

P225 
Induced sputum to assess airways inflammation in psoriatic patients
Damiani G.*, Torelli L., Malerba M. (Trieste, Italy)

P226
Paeoniflorin suppressed IL-22 via p38 MAPK pathway and play Anti-psoriatic effect

yu J., Zhao R., Lu C.* (Guangzhou, China)

P227

Astilbin suppressed IL6 and IL 22 via p38 MAPK pathway and play anti-psoriatic effect
Yu J., Zhao R.*, Lu C. (Guangzhou, China)


Clinical guidelines and recommendations for psoriasis treatment

P228
HBV / HCV infections and psoriasis: the management of patients treated with anti-TNF
Franceschini C.*, Babino G., Giunta A., Esposito M., Di Paolo D., Bianchi L. (Rome, Italy)


Epidemiology and comorbidities in Psoriasis

P229
Comparison between conventional and biological treatment impact on comorbidities in patients with psoriasis- a review of 30 cases
Avram S.*, Solovan C.,  Faiq  Abdulla  Naqeshbandi A. (Timisoara, Romania)

P230

CARDIOVASCULAR RISK FACTORS AND CAROTID INTIMA-MEDIA THICKNESS IN PATIENTS WITH PSORIASIS
Giraldo L.*, Argote A., Mora O., Barrera D., Muñoz L., Camargo D., Aponte L. (Bogotá, Colombia)

P231

Prevalence of Anxiety Symptoms in Psoriasis Patients in Riyadh Hospitals
Alhussain A. H.*, AlDabeis A., Alharbi M. (Riyadh, Saudi Arabia)

P232

Beyond  metabolic and psychiatric  comorbidities in Psoriasis : what’s next ?
Kelati A.*, zinoune S., Mernissi F. Z. (Fes, Morocco)

P233

Cardiovascular risk in psoriasis – possible new circulatory markers in monitoring of the systemic inflammatory process and their impact on associated vascular comorbidities.
Balcewicz B.* (Poznań, Poland)

P234

ASSOCIATION BETWEEN MODERATE TO SEVERE PSORIASIS AND PERIODONTITIS AND EFFICACYOF ANTI-TNFα THERAPY
Babino G.*, Marchetti E., Cannizzaro M. V., Franceschini C., Giunta A., Esposito M., Bianchi L. (Rome, Italy)

 

Psoriasis – pathogenesis

P235
Psoriasis palmoplantaris as an occupational disease. The German Experience.
Hayani K.*, Bachmann K., Diepgen T. (Heidelberg, Germany)

P236

Superimposed Linear Psoriasis: Demonstrative cases for this new genetic concept
Topkarci Z.*, Erdogan B., Kavak A. (Istanbul, Turkey)

P237

Superior efficacy of the fixed combination calcipotriol plus betamethasone dipropionate aerosol foam versus gel, in a sub set of patients with mild to moderate psoriasis vulgaris: a sub-analysis of the Phase III PSO-ABLE study
King C.*, Lowson D. (Ballerup, Denmark)

 

Psoriasis in children and pregnancy

P238
Combination therapy in severe pediatric psoriasis
Solomon I.*, Constantin M., Haiducu L. (Bucharest, Romania)

P239

A case of  severe psoriasis  in  an 1 year old baby .Infant psoriasis case report .
Proca A. N.*, Florea I., Solovan C. (Timisoara, Romania)

P240

Psoriasis in childhood and adolescence : a cohort of 160 patients
Kelati A.*, Fatima Zaha M. (Fes, Morocco)

P241

Psoriasis in childhood: a zoom on the life  quality of 160 moroccan psoriatic child
Kelati A.*, Mernissi F. Z. (Fes, Morocco)

P242

Pediatric Psoriasis: should we be worried about  comorbidities?
Kelati A.*, Mernissi F. Z. (Fes, Morocco)

P243

Penicillin for the treatment of severe plaque psoriasis in children.Case report
Colbu P.*, Trandafir L. M., Chiriac A. et  Emergency Hospital for Children "St. Maria "Iaşi,  Apollonia University of Iasi-Departament of  Dermatology , physiology, pathophysiology (Iasi, Romania)

P244

The effect of maternal psoriasis on pregnancy and birth outcomes
Haerskjold A.*,  Broems G., Granath F., Kieler H., Pedersen L., Anveden Berglind  I. (Copenhagen, Denmark)

 

Scoring and monitoring the severity of the disease

P245
Determination of serum levels of adiponectin, leptin, ghrelin and insulin in  patients with psoriasis
LOPEZ P. A.*, CASTELLANOS H. et DEPARTAMENTO DE CIENCIAS FISIOLÓGICAS Y DEPARTAMENTO DE MEDICINA INTERNA UNIVERSIDAD NACIONAL DE COLOMBIA (MEDELLIN, Colombia)

P246

Determination of serum levels of adiponectin, leptin, ghrelin and insulin in  patients with psoriasis
Lopez P. A.*, CASTELLANOS H. et GRUPO DE INVESTIGACIÓN EN CIENCIAS FISIOLÓGICAS  Y DERMATOLOGÍA UNIVERSIDAD NACIONAL DE COLOMBIA (BOGOTÁ, Colombia)

P247

Patients viewpoint of  psoriasis
Welz-Kubiak K.*, Reich A. (Wroclaw,, Poland)

P248

Relapses in patients with moderate to severe plaque psoriasis treated with biologics according to Spanish clinical practice
Sánchez Carazo J. L.*, Ribera Pibernat M., De la Cueva Dobao P., Fonseca Capdevila E., Dauden Tello E., Mollet Sanchez J., Notario Rosa J. et BIOPRES Study Group (Valencia, Spain)

 

Therapeutics and clinical trials in psoriasis

P249

Ustekinumab in the treatment of psoriasis: experience with a small series of 13 cases
Gencia I., Popa V.-T.*, Solovan C. (Timisoara, Romania)

P250

Psoriasis management : moroccan experience
Kelati A.*, Zinoune S., Fatima zahra M. (Fes, Morocco)

P251

Photoaggravated  psoriasis : a report of 6 cases
Kelati A.*, Mernissi F. Z. (Fes, Morocco)

P252

Association between ustekinumab serum levels, immunogenicity and clinical response in patients with moderate-to-severe psoriasis treated with ustekinumab
Urigoitia-Ugalde P.*, Martín-González S., Navarro-Lobato R., Ruiz del agua A., Blanch-Rius L., Izu-Belloso R. (Bilbao, Spain)

P253

OUR EXPERIENCE WITH SECUKINUMAB IN 18 PATIENTS. A SINGLE-CENTER PROSPECTIVE FOLLOW UP
Corral Magaña O.*, Escalas Taberner J., Giacaman Contreras A., Montis Palos M. D. L. C. (Palma de Mallorca, Spain)

P254

Fixed combination calcipotriol plus betamethasone as dipropionate aerosol foam is more effective than betamethasone 17-valerate medicated plaster in plaque psoriasis
Queille-Roussel C., Rosen M., Clonier F., Nørremark K.* (Ballerup, Denmark)